NYSE: BMY

Price$54.78 Change +0.19 %Change +0.35% Volume: 26,861,211 20 minute delay February 21, 2017

SEC Filings

Date Filing Description Download
Nov 12, 1999 10-Q Quarterly Report
Aug 13, 1999 10-Q Quarterly Report
Jun 28, 1999 SE Form for submission of Paper Format Exhibits by Electronic Filers
May 14, 1999 10-Q Quarterly Report
Mar 30, 1999 10-K Annual Report
Mar 22, 1999 AR/S Paper Annual Report to Security Holders
Mar 19, 1999 DEF 14A Proxy Statement (definitive)
Mar 19, 1999 DEFA14A Additional Proxy Soliciting Materials (definitive)
Mar 03, 1999 PRE 14A Proxy Statement - Notice of Shareholders Meeting (preliminary)
Feb 12, 1999 SC 13D/A Amended Statement of Beneficial Ownership
Feb 01, 1999 NO ACT Public response to a specific request for staff views regarding the federal securities laws or SEC rules, regulations or orders

Materials on this website may contain information about the Company’s future plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. Forward-looking statements contained on this website should be evaluated together with the many uncertainties that affect Bristol-Myers Squibb's business, particularly those identified in the cautionary factors discussion in the company’s most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. These documents are available from the Securities and Exchange Commission, the Bristol-Myers Squibb website or from Bristol-Myers Squibb Investor Relations.

In addition, any information contained on this website was current as of the date presented and should not be relied upon as representing our estimates as of any subsequent date. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our estimates change, whether as a result of new information, future events or otherwise. Consequently, the company will not update the information contained on the website and investors should not rely upon the information as current or accurate after the presentation date. The website may also contain certain non-GAAP financial measures, adjusted to include certain costs, expenses, gains and losses and other specified items. Reconciliations of these non-GAAP financial measures to the most comparable GAAP measures for a particular quarterly period are available on the company’s website at www.bms.com.